Kennedy quietly endorses this fall’s flu vaccine
And more health news of the day.
Related Articles
In internal call, CDC employees recount shooting, ask about RFK Jr.’s response
After a gunman shot up CDC headquarters, employees had harrowing stories and questions about “disinformation that caused this issue.”
In internal call, CDC employees recount shooting, ask about RFK Jr.’s response
After a gunman shot up CDC headquarters, employees had harrowing stories and questions about “disinformation that caused this issue.”
Vinay Prasad returns to the FDA, weeks after his ouster
HFO HFO Vinay Prasad returns to a top FDA role just weeks after his abrupt dismissal.
Former surgeon general: The CDC shooting must be a wakeup call
“When influential figures amplify falsehoods, they legitimize the anger that leads to violence,” writes former Surgeon General Jerome Adams.
Former surgeon general: The CDC shooting must be a wakeup call
“When influential figures amplify falsehoods, they legitimize the anger that leads to violence,” writes former Surgeon General Jerome Adams.
Kennedy’s rejection of mRNA vaccines thwarts scientific progress — and threatens national security, experts say
Health secretary Robert F. Kennedy Jr.’s decision to discontinue funding for mRNA vaccines has alarmed scientists. But it is also a matter of national security,…
Vinay Prasad returns to the FDA, weeks after his ouster
HFO HFO Vinay Prasad returns to a top FDA role just weeks after his abrupt dismissal.
How to Crush a PSMA PET Report: Guidelines and Scoring Systems “Presentation” – Phillip Kuo
At the 2025 UCSF-UCLA PSMA Conference, Phillip Kuo addresses standardized PSMA PET reporting across clinical and research contexts. He reviews frameworks including a proposed template…
HHS cites list of studies as scientific justification for cancellation of mRNA vaccine contracts
HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific justification for canceling contracts.
Lessons from Germany in Early Access PSMA Therapy in Clinical Practice “Presentation” – Wolfgang Fendler
At the 2025 UCSF-UCLA PSMA Conference, Wolfgang Fendler discusses German early access programs for lutetium-PSMA therapy. He highlights five key contributions: actinium-PSMA alpha therapy data;…